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Abstract— This study aimed to take existing anatomical 
models of pregnant women, currently used for radiation pro-
tection and nuclear medicine dose calculations, and adapt 
them for use in the calculation of fetal dose from external 
beam radiotherapy (EBRT). The models investigated were 
‘KATJA’, which was provided as an MCNPX geometry file, 
and ‘RPI-P6’, which was provided in a simple, voxelized bina-
ry format. In-house code was developed, to convert both mod-
els into an `egsphant’ format, suitable for use with 
DOSXYZnrc. The geometries and densities of the resulting 
phantoms were evaluated and found to accurately represent 
the source data. As an example of the use of the phantoms, the 
delivery of a cranial EBRT treatment was simulated using the 
BEAMnrc and DOSXYZnrc Monte Carlo codes and the likely 
out-of-field doses to the fetus in each model was calculated. 
The results of these calculations showed good agreement (with-
in one standard deviation) between the doses calculated in 
KATJA and PRI-P6, despite substantial anatomical differ-
ences between the two models. For a 36 Gy prescription dose 
to a 233.2 cm3 target in the right brain, the mean doses calcu-
lated in a region of interest covering the entire uterus were 1.0 
+/- 0.6 mSv for KATJA and 1.3 +/- 0.9 mSv for RPI-P6. This 
work is expected to lead to more comprehensive studies of 
EBRT treatment plan design and its effects on fetal dose in the 
future. 
Keywords— Radiation therapy, fetal dose, Monte Carlo 
dose calculation, patient protection. 
I. INTRODUCTION  
In any case where the use of external beam radiotherapy 
(EBRT) to treat a pregnant patient is unavoidable, it is im-
portant that the radiation dose to the developing fetus is 
evaluated as accurately as possible. Fetal dose estimates are 
needed when making treatment planning decisions, when 
designing personalized radiation shielding and when provid-
ing the pregnant patient with an appropriate risk assessment.  
To date, estimates of fetal dose from EBRT have been 
made using approximate point-dose calculations or meas-
urements in simple plastic phantoms. For example, the 
American Association of Physicists in Medicine (AAPM) 
have provided a comprehensive list of measurements of out-
of-field dose from square fields in water-equivalent plastic, 
which can be used in estimating fetal dose from radiothera-
py treatments [1]. Several phantom manufacturers have also 
produced anatomical models that can be augmented with 
bolus to obtain point dose measurements in patient-like 
geometries. Typical measurement geometries used for as-
sessing fetal dose are shown in Figure 1.  
 
Fig. 1 Example measurement geometries for evaluating fetal dose from 
cranial radiotherapy. 
However, the use of simplified models to acquire meas-
urement data can lead to substantial uncertainties and the 
use of published out-of-field dose estimates for square fields 
can result in over-estimates or under-estimates of dose, 
when applied to more complex, irregular fields or multiple 
gantry orientations [2]. 
Calculations of out-of-field dose for pregnant patients are 
similarly challenging, given that radiotherapy treatment 
planning systems (RTPSs) are not designed or commis-
sioned to provide accurate dose calculations more than a 
few centimeters beyond the field edge [3] and that, for a 
pregnant patient, the abdominal anatomy should be deliber-
ately excluded (even shielded) from the planning CT [4].  
While simple virtual models, similar to the physical 
models shown in Figure 1, can be generated using CT data 
or using simple geometric definitions and used to calculate 
out-of-field dose via Monte Carlo simulations [5], detailed 
anatomical models suitable for calculating fetal dose from 
EBRT have not previously been available. 
By contrast, increasingly sophisticated models for calcu-
lating dose throughout the body have been used for radia-
tion protection and nuclear medicine since the 1960s [6]. 
The Consortium of Computational Human Phantoms 
(CCHP) maintains a list of (currently more than 100) ana-
tomical models of male and female adults, children and 
infants, including, at the time of writing, seven detailed 
anatomical models of pregnant women [7].  
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This study, therefore, aimed to identify and access suita-
ble radiation safety or nuclear medicine models of pregnant 
patients and adapt those models for use in calculating dose 
from EBRT treatments. This study was also extended to 
demonstrate the use of the resulting models to calculate 
fetal dose from a cranial EBRT treatment and thereby ex-
emplify the detailed information that can be obtained from 
Monte Carlo calculations of out-of-field dose.  
II. MATERIALS AND METHODS 
A. Patient models 
Efficient and accurate Monte Carlo simulations of EBRT 
treatments can be completed using the National Research 
Council Canada’s BEAMnrc and DOSXYZnrc user codes 
[8]. The creation of a dose calculation input file for 
DOSXYZnrc involves converting the patient’s CT into a 
text file (egsphant) that lists voxel boundaries, tissues and 
densities [9,10,11]. In order to generate DOSXYZnrc-
compatible egsphant files it was therefore desirable to use 
anatomical models that were available in voxelized formats. 
 ‘KATJA’, from the German Research Center for Envi-
ronmental Health, was based on the ICRP-AF model, and 
was provided in a simple, voxelised binary format [12]. 
‘RPI-P6’, from the Rensselaer Polytechnic Institute, was 
based on contours of CT data and was provided as an 
MCNPX geometry file [13,14,15]. Both of these models 
provided detailed, anatomical descriptions of women at 
approximately the sixth month of pregnancy, but the ge-
ometries and material definitions used in the two models 
differed from each other, as indicated in Table 1.   
Table 1 Physical characteristics of anatomical phantoms 
Feature RPI-P6 KATJA 
Height 163.5 cm 168.4 cm 
Weight  60.3 kg 
Maximum thickness  
(ant-post) 
38.1 cm 26.6 cm 
Number of defined organs 
in patient 
31 141 
Number of defined organs 
in fetus  
3 21*  
Fetal orientation 
Head down,  
spine to ant 
Head down,  
spine to left 
Term 26.5 weeks 24 weeks 
Number of voxels (x, y, z) (182, 127, 545)  (299, 150, 348) 
Voxel size (x, y, z) (mm)  (3, 3, 3)  (1.775, 1.775, 4.84) 
Data source 
Pregnant patient CT 
combined with VIP-
Man model 
Modified ICRP-AF 
model 
Data type MCNPX geo file Binary 
* Includes umbilical cord, amniotic fluid & placenta 
 
The RPI-P6 had been used previously to calculate radia-
tion doses from internal nuclear medicine sources using the 
MCNPX Monte Carlo code [14,15], however there were 
major differences between the required formatting of 
DOSXYZnrc egsphant files [17] and the format of the RPI-
P6 file. In-house code was therefore written in the C# pro-
gramming language, to read in the RPI-P6 geo file and 
associated material densities and generate a DOSXYZnrc 
egsphant file for the RPI-P6 model. 
The KATJA binary file was provided with a separate 
document listing the 162 organs used in the KATJA model, 
without material density information. In order to convert 
KATJA into a DOSXYZnrc egsphant input file it was nec-
essary to assign densities to these 162 organs and to catego-
rize them into no more than 9 different tissue types [17,18]. 
The organ density data provided with the RPI-P6 model 
were used to specify the densities of the organs in the 
KATJA model. A second in-house code was written to read 
the binary file and the other required information and pro-
duce a DOSXYZnrc egsphant file for the KATJA model. 
When writing each egsphant, care was taken place the 
origin at the superior end of the phantom (useful for simu-
lating cranial treatments), while preserving the lateral orien-
tation of each model (heart on the left-hand side). 
B. Treatment simulation 
A clinical treatment plan from a recent treatment of an 
oligodendroglioma of the right brain was used to demon-
strate the practical use of the anatomical models produced 
in this study. This treatment was selected for simulation 
because it involved a large (approx. 6 cm diameter) brain 
tumor, which would pose a substantial risk to patient sur-
vival if left untreated for the term of a pregnancy [20]. The 
treatment plan was also identified as being suitable for hy-
pothetical delivery to a pregnant patient, because it involved 
no superior-oblique (non-coplanar) beams and it consistent-
ly used a 90° collimator angle that aligned the linear accel-
erator’s multi-leaf collimator (MLC) with the longitudinal 
patient direction, providing additional shielding from out-
of-field dose [3,21].  
The treatment was planned using the Varian Eclipse 
treatment planning system, for delivery via a Varian iX 
linear accelerator (Varian Medical Systems, Palo Alto, 
USA). The 233.2 cm
3
 planning target volume (PTV) was 
treated to 36 Gy in 20 fractions, using five conformal pho-
ton beams with a 6 MV nominal energy.  
The treatment plan was exported from the planning sys-
tem as a DICOM RT PLAN object and processed using 
Crowe et al’s MCDTK code [22,23], to produce input files 
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for use with our established Monte Carlo model  of the 
Varian iX linear accelerator (linac) [16,19].  
DOSXYZnrc was used to calculate the dose deposited in 
and around KATJA and RPI-P6 by each of the seven beams 
in the cranial treatment plan. In order to provide dose calcu-
lations with adequate statistical precision (0.3% in the PTV 
and 10% in the uterus), the irradiation of each of the two 
phantoms by each of the seven beams in the treatment was 
simulated using 2,000,000,000 particles, with each beam 
simulation shared across 50 of the processors of a 1924 core 
SGI Altix supercomputing cluster (Silicon Graphics Inc, 
Milpitas, USA). The total calculation time was 10,500 
hours, but parallelization (mitigated by the need to share 
resource usage via a queuing system) meant that all 
DOSXYZnrc calculations were completed within 48 hours 
of submission. 
In the 3D dose distributions produced by these simula-
tions, the following ROIs were selected for evaluation: (a) 4 
cm
2
 areas at 5cm intervals from the anterior to the posterior 
side of the patient, at the level of the superior end of the 
uterus, (b) 4 cm
2
 areas at 5cm intervals from the superior to 
the inferior end of the ‘baby bump’, and (c) the entire vol-
ume of the uterus. ROIs (a) and (b) were chosen to indicate 
some possible ‘worst case scenario’ doses that might be 
delivered to small regions of the fetal anatomy, while region 
(c) was used to provide an evaluation of the overall dose to 
the uterus, placenta and fetus, in each of the models. 
This method included all sources of out-of-field dose (ra-
diation leakage from the linac head, scatter of the primary 
beam from the linac head and the intervening air, and scatter 
of the primary beam within the patient) in the simulation. 
III. RESULTS 
A. Model conversion 
 
Fig. 2 Sagittal slices through (a) KATJA and (b) RPI-P6, shown as grey-
scale density maps (lighter grey represents higher densities and darker grey 
represents lower density). 
The two C# phantom model conversion codes required 
for this work produced faithful egsphant versions of the 
KATJA and RPI-P6 anatomical models. Figures 2(a) and 
(b) show greyscale renderings of the egsphant files pro-
duced for KATJA and RPI-P6, respectively. The heights, 
thicknesses and total masses of the phantoms matched the 
values listed in Table 1 and the densities of the organs de-
fined in the phantoms matched their assigned values. 
B. Treatment dose 
The simulated irradiation of each of the two phantoms by 
the five-field, 36 Gy, oligodendroglioma treatment pro-
duced the ROI doses shown in Figure 3. Most mean ROI 
doses calculated in RPI-P6 are higher than the ROI doses 
calculated in KATJA, especially at the superior end of the 
uterus, due to the increased prominence of RPI-P6’s baby 
bump and its consequent closer proximity to the photon 
source. However, these results show good agreement (with-
in one standard deviation) between the doses calculated in 
KATJA and the doses calculated in RPI-P6, despite sub-
stantial anatomical differences. This suggests that anatomi-
cal variation does not negate the usefulness of the models: 
Figure 3 may be regarded as providing an indication of the 
fetal doses to be expected if a pregnant patient with a simi-
lar height and build to KATJA and RPI-P6 received the 
oligodendroglioma treatment used in this study.   
 
Fig. 3 Mean simulated doses in the ROIs listed in Section II.B, for the PRI-
P6 and KATJA patient models (error bars represent +/- 1SD). 
While most of the doses shown in Figure 3 exceed the 1 
mSv annual dose limit recommended for the general public 
[24], they are nonetheless relatively low, around 50 times 
lower than the maximum leakage dose permitted 100 cm 
4 
from the photon source in a medical linear accelerator [25] 
and 10,000 times lower than the dose delivered to the PTV.  
IV. CONCLUSIONS  
This study has demonstrated that anatomical models de-
signed for radiation safety and nuclear medicine dose calcu-
lations can be successfully adapted for use in EBRT out-of-
field dose calculation and that the results of such calcula-
tions may be relatively insensitive to anatomical variation. 
This work is expected to lead to more comprehensive stud-
ies of EBRT treatment plan design and its effects on fetal 
dose in the future. The novel codes developed for this study 
may be used to produce Monte Carlo simulation files from 
other radiation safety models, including pediatric patients of 
various ages.  
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